256 related articles for article (PubMed ID: 34207804)
1. Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives.
Hardouin P; Chiron R; Marchandin H; Armengaud J; Grenga L
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207804
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of hosts and pathogens in cystic fibrosis.
Kamath KS; Kumar SS; Kaur J; Venkatakrishnan V; Paulsen IT; Nevalainen H; Molloy MP
Proteomics Clin Appl; 2015 Feb; 9(1-2):134-46. PubMed ID: 25418359
[TBL] [Abstract][Full Text] [Related]
3. The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease.
Puglia M; Landi C; Gagliardi A; Breslin L; Armini A; Brunetti J; Pini A; Bianchi L; Bini L
J Proteomics; 2018 Jan; 170():28-42. PubMed ID: 28970102
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
5. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
[TBL] [Abstract][Full Text] [Related]
6. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
7. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome.
Peters-Hall JR; Brown KJ; Pillai DK; Tomney A; Garvin LM; Wu X; Rose MC
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):22-32. PubMed ID: 25692303
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
12. Function is what counts: how microbial community complexity affects species, proteome and pathway coverage in metaproteomics.
Lohmann P; Schäpe SS; Haange SB; Oliphant K; Allen-Vercoe E; Jehmlich N; Von Bergen M
Expert Rev Proteomics; 2020 Feb; 17(2):163-173. PubMed ID: 32174200
[No Abstract] [Full Text] [Related]
13. Targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane.
McShane AJ; Bajrami B; Ramos AA; Diego-Limpin PA; Farrokhi V; Coutermarsh BA; Stanton BA; Jensen T; Riordan JR; Wetmore D; Joseloff E; Yao X
J Proteome Res; 2014 Nov; 13(11):4676-85. PubMed ID: 25227318
[TBL] [Abstract][Full Text] [Related]
14. The Microbiome in Cystic Fibrosis Pulmonary Disease.
Françoise A; Héry-Arnaud G
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403302
[TBL] [Abstract][Full Text] [Related]
15. Molecular ecological tools to decipher the role of our microbial mass in obesity.
Hermes GD; Zoetendal EG; Smidt H
Benef Microbes; 2015 Mar; 6(1):61-81. PubMed ID: 24902956
[TBL] [Abstract][Full Text] [Related]
16. An integrated metaproteomics workflow for studying host-microbe dynamics in bronchoalveolar lavage samples applied to cystic fibrosis disease.
Kruk ME; Mehta S; Murray K; Higgins L; Do K; Johnson JE; Wagner R; Wendt CH; O'Connor JB; Harris JK; Laguna TA; Jagtap PD; Griffin TJ
mSystems; 2024 Jun; ():e0092923. PubMed ID: 38934598
[TBL] [Abstract][Full Text] [Related]
17. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
18. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.
Mall MA; Mayer-Hamblett N; Rowe SM
Am J Respir Crit Care Med; 2020 May; 201(10):1193-1208. PubMed ID: 31860331
[TBL] [Abstract][Full Text] [Related]
19. Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis.
Benabdelkamel H; Alamri H; Okla M; Masood A; Abdel Jabar M; Alanazi IO; Alfadda AA; Nizami I; Dasouki M; Abdel Rahman AM
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050003
[TBL] [Abstract][Full Text] [Related]
20. Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
Hare NJ; Soe CZ; Rose B; Harbour C; Codd R; Manos J; Cordwell SJ
J Proteome Res; 2012 Feb; 11(2):776-95. PubMed ID: 22054071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
